Paper1390331
Choice of ACE inhibitor for congestive heart failure.
Opie LH. Cardiovasc Drugs Ther, 1992. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Choice of ACE inhibitor for congestive heart failure. Papers, record 1390331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1390331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Captopril | Major topic |
| Enalapril | Major topic |
| Heart Failure | Major topic |
| Dose-Response Relationship, Drug | |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 1390330 | Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function. | https://conductscience.org/library/papers/1390330 |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3018566 | Comparison of captopril and enalapril in patients with severe chronic heart failure. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3018566 | PubMed |
| 2 | 2562137 | Low-dose enalapril in severe chronic heart failure. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2562137 | PubMed |
| 3 | 2057035 | A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. | N Engl J Med | 1991 | https://conductscience.org/library/papers/2057035 | PubMed |
| 4 | 1676239 | Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. | Am J Cardiol | 1991 | https://conductscience.org/library/papers/1676239 | PubMed |
| 5 | 2015167 | Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine. | Br J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/2015167 | PubMed |
| 6 | 1390330 | Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function. | Cardiovasc Drugs Ther | 1992 | https://conductscience.org/library/papers/1390330 | PubMed |
| 7 | 2057034 | Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. | N Engl J Med | 1991 | https://conductscience.org/library/papers/2057034 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1390331
GET https://conductscience.org/api/papers/v1/1390331/authors